Related Experiment Video
Updated: Sep 20, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Tools for Identifying Potentially Inappropriate Prescriptions for Children and Their Applicability in Clinical
Siyu Li1,2,3,4, Liang Huang1,2,3, Zhe Chen1,2,3
1Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu, China.
Insights
Potentially inappropriate prescription screening tools for children are limited, with most lacking validation. Developing and validating national tools is crucial for improving pediatric drug safety and rational prescribing.
Area of Science:
- Pharmacovigilance and Drug Safety
- Pediatric Pharmacology
- Health Services Research
Background:
- Drug use safety in children is a significant global public health concern.
- Potentially inappropriate prescription (PIP) screening tools aim to minimize adverse drug reactions and promote rational medication use in pediatric populations.
Approach:
- A systematic literature search was conducted across six major databases (PubMed, Embase, Cochrane Library, CNKI, VIP, Wanfang Data).
- Two independent reviewers selected eligible articles and extracted relevant data.
- Evaluated were the disease/drug coverage and item consistency among identified pediatric PIP screening tools.
Key Points:
- Five pediatric PIP screening tools were identified, primarily developed via Delphi expert consensus, focusing on respiratory, anti-infective, and gastrointestinal drugs.
- Significant variability in item overlap was observed between tools (e.g., POPI and POPI Int: 82.0%, POPI UK and PIPc: 2.2%), with KIDs List showing no overlap.
- Only the French POPI tool demonstrated comprehensive validation; most other tools lack robust validation studies for clinical applicability.
Conclusions:
- The field of pediatric potentially inappropriate prescribing screening tools is underdeveloped, with a critical need for validated instruments.
- Future research should focus on developing and validating national PIP screening tools for children, grounded in robust clinical evidence and country-specific contexts.
Abstract:
Background: Drug use safety in children is a global public health problem. The potentially inappropriate prescription screening tools are expected to reduce adverse drug reactions and promote rational drug use. Objectives: To systematically evaluate children's potentially inappropriate prescription screening tools and validation studies on these tools. Methods: We systematically searched six databases PubMed, Embase, Cochrane Library, CNKI, VIP and Wanfang Data. Two reviewers independently selected articles by the eligible criteria and extracted data. Then we evaluated the coverage of diseases or drugs in these tools and the consistency of items between tools. Results: Five children's potentially inappropriate prescription screening tools were identified, most tools were formed by Delphi expert consensus and focused on respiratory system drugs, anti-infective drugs, and gastrointestinal drugs. The coincidence rates of items between the POPI and the POPI Int, the POPI and the POPI United Kingdom, the POPI United Kingdom and the POPI int, and the POPI United Kingdom and the PIPc were 82.0, 55.1, 51.0 and 2.2% respectively, and the KIDs List did not overlap other four tools. Only the POPI tool developed by French experts was comprehensively validated by studies and most tools have not been validated. Conclusion: The development of screening tools for potentially inappropriate prescribing in children is a neglected field and most tools lack studies to validate clinical applicability. More researchers need to form their national potentially inappropriate prescription screening tools for children based on the best available clinical evidence and the actual clinical situation in their countries.
Related Concept Videos
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Factors Affecting Drug Response: Overview
Drug Classes and Categories
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Analysis of Population Pharmacokinetic Data
Drug Regulation

